(10), assessing inflammatory mediators in sputum from 12 adult CF patients carrying a G551D mutation: the authors found a significant decrease of IL-1β, IL-8 and NE levels in sputum during therapy with ivacaftor in a comparable cohort (n=12). This evidence concerns the gene CXCL8 and cystic fibrosis.